Miki T - Search Results

1

The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.

Fujiwara J, Sowa Y, Horinaka M, Koyama M, Wakada M, Miki T, Sakai T. Fujiwara J, et al. Among authors: miki t. Int J Oncol. 2012 May;40(5):1483-91. doi: 10.3892/ijo.2012.1353. Epub 2012 Feb 2. Int J Oncol. 2012. PMID: 22328338

2

[Hormonal chemotherapy for hormone-refractory prostate cancer].

Nishimura K, Nakai Y, Shimizu K, Tokizane T, Arai Y, Inoue H, Takaha N, Nonomura N, Okuyama A, Kamoi K, Ukimura O, Miki T, Koide T, Ichikawa Y, Nishimura K, Sugao H, Yamaguchi S, Takatera H, Uchida K, Miura H. Nishimura K, et al. Among authors: miki t. Hinyokika Kiyo. 2002 Nov;48(11):713-8. Hinyokika Kiyo. 2002. PMID: 12512147 Free article. Review. Japanese.

3

Isoliquiritigenin inhibits the growth of prostate cancer.

Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A, Sakai T, Baba M, Okuyama T, Nishino H, Miki T. Kanazawa M, et al. Among authors: miki t. Eur Urol. 2003 May;43(5):580-6. doi: 10.1016/s0302-2838(03)00090-3. Eur Urol. 2003. PMID: 12706007

4

Genistein induces Gadd45 gene and G2/M cell cycle arrest in the DU145 human prostate cancer cell line.

Oki T, Sowa Y, Hirose T, Takagaki N, Horinaka M, Nakanishi R, Yasuda C, Yoshida T, Kanazawa M, Satomi Y, Nishino H, Miki T, Sakai T. Oki T, et al. Among authors: miki t. FEBS Lett. 2004 Nov 5;577(1-2):55-9. doi: 10.1016/j.febslet.2004.09.085. FEBS Lett. 2004. PMID: 15527761 Free article.

5

Differential response at the hGABP/E4TF1 site of retinoblastoma gene promoter in human testicular seminoma cells.

Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Shiraishi T, et al. Among authors: miki t. Oncol Rep. 2005 May;13(5):871-4. Oncol Rep. 2005. PMID: 15809752

6

Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein.

Yoshida T, Shiraishi T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Yoshida T, et al. Among authors: miki t. Cancer Res. 2005 Jul 1;65(13):5662-7. doi: 10.1158/0008-5472.CAN-05-0693. Cancer Res. 2005. PMID: 15994939

7

Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.

Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T. Shiraishi T, et al. Among authors: miki t. Cancer Res. 2005 Jul 15;65(14):6364-70. doi: 10.1158/0008-5472.CAN-05-0312. Cancer Res. 2005. PMID: 16024639

8

Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.

Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. Hirota E, et al. Among authors: miki t. Int J Oncol. 2006 Oct;29(4):799-827. Int J Oncol. 2006. PMID: 16964377

9

Gene therapy with TRAIL against renal cell carcinoma.

Matsubara H, Mizutani Y, Hongo F, Nakanishi H, Kimura Y, Ushijima S, Kawauchi A, Tamura T, Sakata T, Miki T. Matsubara H, et al. Among authors: miki t. Mol Cancer Ther. 2006 Sep;5(9):2165-71. doi: 10.1158/1535-7163.MCT-05-0522. Mol Cancer Ther. 2006. PMID: 16985049

10

The significance of the expression of dihydropyrimidine dehydrogenase in prostate cancer.

Li Y, Mizutani Y, Shiraishi T, Nakamura T, Mikami K, Takaha N, Okihara K, Kawauchi A, Sakai T, Miki T. Li Y, et al. Among authors: miki t. BJU Int. 2007 Mar;99(3):663-8. doi: 10.1111/j.1464-410X.2006.06606.x. Epub 2006 Nov 7. BJU Int. 2007. PMID: 17092280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,866 results

Search Page